Literature DB >> 15792541

Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant.

Masahiro Yoneda1, Hidetomi Terai, Yuuki Imai, Takao Okada, Kazutoshi Nozaki, Hikaru Inoue, Shimpei Miyamoto, Kunio Takaoka.   

Abstract

Recombinant human bone morphogenetic protein (rhBMP)-2 in a block copolymer composed of poly-D,L-lactic acid with randomly inserted p-dioxanone and polyethylene glycol (PLA-DX-PEG) as a carrier and porous beta-tricalcium phosphate (beta-TCP) blocks were used to generate a new fully absorbable osteogenic biomaterial. The bone regenerability of the rhBMP-2/PLA-DX-PEG/beta-TCP composite was studied in a critical-sized rabbit bone defect model. In an initial study, a composite of PLA-DX-PEG (250 mg) and beta-TCP (300 mg) loaded with or without rhBMP2 (50 microg) was implanted into a 1.5 cm intercalated bone defect created in a rabbit femur. Defects were assessed by biweekly radiography until 8 weeks postoperatively. The bony union of the defect was recognized only in the BMP-loaded group. To obtain further data on biomechanical and remodeling properties, another BMP-loaded composites group was made and observed up to 24 weeks. All defects were completely repaired without residual traces of implants. Anatomical and mechanical properties of the repaired bone examined by histology, 3-dimensional CT (3D-CT) and mechanical testing were essentially equivalent to the nonoperated-on femur at 24 weeks. These experimental results indicate that fully absorbable rhBMP-2/PLA-DX-PEG/beta-TCP is a promising composite having osteogenicity efficient enough for repairing large bone defects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15792541     DOI: 10.1016/j.biomaterials.2005.01.054

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  19 in total

1.  Microporous poly(L-lactic acid) membranes fabricated by polyethylene glycol solvent-cast/particulate leaching technique.

Authors:  Shivaram Selvam; Wenji V Chang; Tamako Nakamura; Deedar M Samant; Padmaja B Thomas; Melvin D Trousdale; Austin K Mircheff; Joel E Schechter; Samuel C Yiu
Journal:  Tissue Eng Part C Methods       Date:  2009-09       Impact factor: 3.056

2.  Bioactive factors for tissue regeneration: state of the art.

Authors:  Shinsuke Ohba; Hironori Hojo; Ung-Il Chung
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

3.  Alternatives to autograft evaluated in a rabbit segmental bone defect.

Authors:  Jennifer S McDaniel; Marcello Pilia; Vivek Raut; Jeffrey Ledford; Stefanie M Shiels; Joseph C Wenke; Brian Barnes; Christopher R Rathbone
Journal:  Int Orthop       Date:  2015-07-09       Impact factor: 3.075

4.  Escherichia coli-derived BMP-2-absorbed β-TCP granules induce bone regeneration in rabbit critical-sized femoral segmental defects.

Authors:  Yu Kuroiwa; Takahiro Niikura; Sang Yang Lee; Keisuke Oe; Takashi Iwakura; Tomoaki Fukui; Tomoyuki Matsumoto; Takehiko Matsushita; Kotaro Nishida; Ryosuke Kuroda
Journal:  Int Orthop       Date:  2018-08-10       Impact factor: 3.075

5.  Recombinant human bone morphogenetic protein-2 (rhBMP-2) in the treatment of mandibular sequelae after tumor resection.

Authors:  André Zétola; Felipe Mussi Ferreira; Rafaela Larson; Jamil Awad Shibli
Journal:  Oral Maxillofac Surg       Date:  2010-06-24

6.  Biodegradable PEG-Based Amphiphilic Block Copolymers for Tissue Engineering Applications.

Authors:  Artem B Kutikov; Jie Song
Journal:  ACS Biomater Sci Eng       Date:  2015-05-26

Review 7.  Studies of bone morphogenetic protein-based surgical repair.

Authors:  Kevin W-H Lo; Bret D Ulery; Keshia M Ashe; Cato T Laurencin
Journal:  Adv Drug Deliv Rev       Date:  2012-04-02       Impact factor: 15.470

8.  Results of a bone splint technique for the treatment of lower limb deformities in children with type I osteogenesis imperfecta.

Authors:  Dasheng Lin; Wenliang Zhai; Kejian Lian; Zhenqi Ding
Journal:  Indian J Orthop       Date:  2013-07       Impact factor: 1.251

9.  Antitumor necrotic factor agent promotes BMP-2-induced ectopic bone formation.

Authors:  Yoshitaka Eguchi; Shigeyuki Wakitani; Yuuki Imai; Yoshifumi Naka; Yuusuke Hashimoto; Hiroaki Nakamura; Kunio Takaoka
Journal:  J Bone Miner Metab       Date:  2009-10-29       Impact factor: 2.626

10.  A study of the role of nell-1 gene modified goat bone marrow stromal cells in promoting new bone formation.

Authors:  Tara Aghaloo; Xinquan Jiang; Chia Soo; Zhiyuan Zhang; Xiuli Zhang; Jingzhou Hu; Hongya Pan; Tiffany Hsu; Benjamin Wu; Kang Ting; Xinli Zhang
Journal:  Mol Ther       Date:  2007-07-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.